Siegfried

Siegfried, founded in 1873, is a prominent player in the pharmaceutical and healthcare industries, specializing in the research and manufacturing of pharmaceuticals. With its headquarters located in Aargau, Switzerland, the company has established a long-standing reputation for its contributions to drug development and production. Its operations span across various facets of the pharmaceutical value chain, from early-stage research to commercial-scale manufacturing.

Operating with a workforce of 1,000-5,000 employees across 6 locations, Siegfried offers a comprehensive suite of services. These include contract development, API manufacturing, and integrated pharmaceutical solutions. The company's expertise covers critical areas such as clinical trial support, drug formulation, and specialized manufacturing processes like powder handling, inhalation, capsule filling, and milling. For insights into their organizational structure and personnel, you can Meet Siegfried's team.

Siegfried's product portfolio and services are designed for scalability, supporting clients from pilot batches to commercial production. They provide development services for APIs and finished dosage forms, emphasizing quality, compliance, and a customer-centric approach. The company generated a revenue of $1.3B, underscoring its significant market presence. Its ticker symbol is SIX: SFZN.SW, reflecting its status as a publicly traded entity.